The update may make mifepristone and misoprostol more readily available worldwide. But in the U.S., not much is expected to change.
This research is particularly important at a time when states across the country are passing new laws concerning abortion.
Women who sought but did not receive an abortion were in worse health five years later than peers who did get one, a new study finds.
The FDA writes that failure to immediately cease sales of unapproved versions of mifepristone and misoprostol may result in action.
The research on the consequences of Planned Parenthood losing public funding offers a sense of what may happen.
Pacific Standard spoke with Blanca Cuevas, the director of a reproductive health non-profit based on the island.
Abortion rights activists comfort each other outside the National Congress in Buenos Aires, Argentina, on August 9th, 2018, after senators rejected a bill that would have legalized abortion.
Abby Norman's new book chronicles how her endometriosis diagnosis unfolded alongside the medical disbelief around her chronic, debilitating pain.
The side effects are significant, but mostly people feel fine afterwards.
A new report details the rapid growth of Catholic health care networks, and the questions and concerns that have attended it.